User profiles for Daniel A. Sweeney

Daniel A. Sweeney

UCSD
Verified email at ucsd.edu
Cited by 15862

Management of adults with hospital-acquired and ventilator-associated pneumonia: 2016 clinical practice guidelines by the Infectious Diseases Society of America …

…, M Klompas, J Muscedere, DA Sweeney… - Clinical infectious …, 2016 - academic.oup.com
It is important to realize that guidelines cannot always account for individual variation among
patients. They are not intended to supplant physician judgment with respect to particular …

[HTML][HTML] Remdesivir for the treatment of Covid-19

…, TF Patterson, R Paredes, DA Sweeney… - … England Journal of …, 2020 - Mass Medical Soc
Background Although several therapeutic agents have been evaluated for the treatment of
coronavirus disease 2019 (Covid-19), no antiviral agents have yet been shown to be …

Remdesivir for the treatment of Covid-19—preliminary report

…, TF Patterson, R Paredes, DA Sweeney… - … England Journal of …, 2020 - discovery.ucl.ac.uk
BACKGROUND: Although several therapeutic agents have been evaluated for the treatment
of coronavirus disease 2019 (Covid-19), no antiviral agents have yet been shown to be …

[HTML][HTML] Baricitinib plus remdesivir for hospitalized adults with Covid-19

…, NM Iovine, MK Jain, DA Sweeney… - … England Journal of …, 2021 - Mass Medical Soc
Background Severe coronavirus disease 2019 (Covid-19) is associated with dysregulated
inflammation. The effects of combination treatment with baricitinib, a Janus kinase inhibitor, …

Executive summary: management of adults with hospital-acquired and ventilator-associated pneumonia: 2016 clinical practice guidelines by the Infectious Diseases …

…, M Klompas, J Muscedere, DA Sweeney… - Clinical Infectious …, 2016 - academic.oup.com
It is important to realize that guidelines cannot always account for individual variation among
patients. They are not intended to supplant physician judgment with respect to particular …

[HTML][HTML] Efficacy of interferon beta-1a plus remdesivir compared with remdesivir alone in hospitalised adults with COVID-19: a double-blind, randomised, placebo …

…, CI Paules, D Ince, J Takasaki, DA Sweeney… - The lancet respiratory …, 2021 - thelancet.com
Background Functional impairment of interferon, a natural antiviral component of the
immune system, is associated with the pathogenesis and severity of COVID-19. We aimed to …

[HTML][HTML] How to use biomarkers of infection or sepsis at the bedside: guide to clinicians

…, A Rouze, J Salluh, M Singer, DA Sweeney… - Intensive care …, 2023 - Springer
Sepsis is defined as a life-threatening organ dysfunction caused by a dysregulated host
response to infection. In this context, biomarkers could be considered as indicators of either …

Baricitinib versus dexamethasone for adults hospitalised with COVID-19 (ACTT-4): a randomised, double-blind, double placebo-controlled trial

…, M Holodniy, ES Kim, DA Sweeney… - The lancet respiratory …, 2022 - thelancet.com
Background Baricitinib and dexamethasone have randomised trials supporting their use for
the treatment of patients with COVID-19. We assessed the combination of baricitinib plus …

[BOOK][B] Sandtray therapy: A practical manual

LE Homeyer, DS Sweeney - 2022 - taylorfrancis.com
… Homeyer and Daniel S. Sweeney to be identified as authors of this work has been asserted
in accordance with sections 77 and 78 of the Copyright, Designs and Patents Act 1988. …

Infectious Diseases Society of America position paper: recommended revisions to the national severe sepsis and septic shock early management bundle (SEP-1) …

…, H Masur, EJ Septimus, DA Sweeney… - Clinical Infectious …, 2021 - academic.oup.com
The Centers for Medicare & Medicaid Services’ Severe Sepsis and Septic Shock Early
Management Bundle (SEP-1) measure has appropriately established sepsis as a national priority…